CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 110 filers reported holding CYTOMX THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $27,000 | -32.5% | 15,186 | 0.0% | 0.00% | – |
| Q1 2022 | $40,000 | -25.9% | 15,186 | +83.1% | 0.00% | – |
| Q4 2020 | $54,000 | +575.0% | 8,292 | +761.1% | 0.00% | – |
| Q2 2020 | $8,000 | -97.9% | 963 | -98.1% | 0.00% | -100.0% |
| Q1 2020 | $380,000 | -7.8% | 49,600 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $412,000 | +9.3% | 49,600 | -3.1% | 0.00% | 0.0% |
| Q3 2019 | $377,000 | -34.3% | 51,200 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $574,000 | +4.4% | 51,200 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $550,000 | -6.9% | 51,200 | +30.6% | 0.00% | 0.0% |
| Q4 2018 | $591,000 | -18.5% | 39,200 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $725,000 | – | 39,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,877,148 | $13,853,000 | 1.46% |
| Congress Park Capital LLC | 167,811 | $1,238,000 | 1.04% |
| Perceptive Advisors | 3,253,923 | $24,014,000 | 0.65% |
| RTW INVESTMENTS, LP | 990,463 | $7,310,000 | 0.44% |
| Spark Investment Management LLC | 337,164 | $2,488,000 | 0.32% |
| Exane Asset Management | 54,065 | $399,000,000 | 0.31% |
| DAFNA Capital Management LLC | 100,000 | $738,000 | 0.28% |
| HARBOURVEST PARTNERS LLC | 79,193 | $584,000 | 0.24% |
| WELD CAPITAL MANAGEMENT LLC | 86,363 | $637,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 77,997 | $576,000 | 0.08% |